DOCSLIB.ORG

PERVASIVE CAUSES of DISEASE by Ronald N. Kostoff, Ph.D

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
PERVASIVE CAUSES of DISEASE by Ronald N. Kostoff, Ph.D Pervasive Causes of Disease Copyright © 2015 Ronald N. Kostoff PERVASIVE CAUSES OF DISEASE by Ronald N. Kostoff, Ph.D. Research Affiliate, School of Public Policy, Georgia Institute of Technology CITATION TO BOOK Kostoff, Ronald N. Pervasive Causes of Disease. Georgia Institute of Technology. 2015. PDF. < http://hdl.handle.net/1853/53714 > 1 Pervasive Causes of Disease Copyright © 2015 Ronald N. Kostoff COPYRIGHT AND CREATIVE COMMONS LICENSE COPYRIGHT Copyright © 2015 by Ronald N. Kostoff Printed in the United States of America; First Printing, 2015 CREATIVE COMMONS LICENSE This work can be copied and redistributed in any medium or format provided that credit is given to the original author. For more details on the CC BY license, see: http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License<http://creativecommons.org/licenses/by/4.0/>. 2 Pervasive Causes of Disease Copyright © 2015 Ronald N. Kostoff DISCLAIMERS The views in this book are solely those of the author, and do not represent the views of the Georgia Institute of Technology. This book is not intended as a substitute for the medical advice of physicians. The reader should regularly consult a physician in matters relating to his/her health and particularly with respect to any symptoms that may require diagnosis or medical attention. Any information in the book that the reader chooses to implement should be done under the strict guidance and supervision of a licensed health care practitioner. 3 Pervasive Causes of Disease Copyright © 2015 Ronald N. Kostoff PREFACE Why did I write this book, what are its contents, what is new, who is the intended audience, and how will readers benefit from it? Motivation For most of the past decade, I have been developing text mining procedures to identify potential discovery of new treatments for serious diseases. During this period, it became clear to me that discovery of new treatments for serious diseases, while both interesting and challenging, would be insufficient to reverse or eliminate disease. It became evident that eliminating the foundational causes of disease was at least as important as applying new treatments, if there were to be any hope for full or partial reversal of disease. Toward that end, I developed a holistic medical principle that would form the bedrock of a healing protocol: Removal of cause is a necessary, but not sufficient, condition for restorative treatment to be effective (where 'removal' encompasses 'neutralization' in those cases where actual 'removal' is not possible). To prevent any disease, the foundational causes that underlay the disease symptoms need to be identified and removed as comprehensively, thoroughly, and rapidly as possible. To reverse disease (if irreversible damage has not been done and genetic predisposition is not a dominant factor), the preventive steps above need to be implemented as well. If the preventive protocols are inadequate for reversing disease progression, they need to be augmented by treatments. The first step in either disease prevention or reversal is to identify the full spectrum of potential foundational causes, or contributing factors, for the disease(s) of interest. It also became evident to me that much of the information required to identify and eliminate these foundational causes of disease is in the literature already, but is not being extracted and exploited adequately. There is little financial incentive for much of the research community to focus on eliminating causes relative to instituting new treatments. Additionally, extracting these foundational causes comprehensively from the literature is a complex text mining problem. I firmly believe that the Literature-Related Discovery and Innovation (LRDI) text mining approach I had been developing for more than a decade is uniquely capable of identifying these foundational causes (and treatments) comprehensively. About three years ago, I started a series of proof-of-principle demonstrations to show that foundational causes (and treatments, in some cases) could be identified comprehensively and efficiently for single diseases. In these demonstrations, I have been identifying an order of magnitude more foundational causes for each disease than any other published papers have reported. However, it became clear to me that identifying foundational causes for any one disease provides a limited perspective on the potential comprehensive damage resulting from foundational causes. To produce a deeper understanding of the health degradation and restoration processes, foundational causes for 'all' diseases collectively need to be identified. 4 Pervasive Causes of Disease Copyright © 2015 Ronald N. Kostoff Moreover, it also became clear to me that many foundational causes are not seeing the light of day in the published literature for myriad reasons, and those unpublished foundational causes might be as important, if not more important, than those appearing in the published literature. Thus, not only would the foundational causes for all diseases have to be addressed in any documentation of such a massive study, but the unique text mining approach that generated these foundational causes would have to be examined in detail, and the myriad reasons for foundational causes having been excluded from the published literature would have to be addressed as well. The study identifying foundational causes for 'all' diseases was initiated in early 2014, and fully completed in 2015. Then, the issue of appropriate documentation arose. My initial thoughts were to publish a series of journal articles. One or more articles would address the voluminous foundational causes that were identified, at least one article would address the innovative text mining approach that generated these results, and at least one article would address the many reasons important foundational causes are being excluded from the biomedical literature. Unfortunately, the separate journal publication approach would have fragmented the results, and would have greatly decremented the value of an integrated interdisciplinary presentation. Producing a book allowed a full exposition and integration of the study's results and conclusions, not constrained by journal limitations. Contents The overall theme of this book is preventing and reversing chronic diseases using the holistic medical principle: removal of cause is a necessary, but not sufficient, condition for restorative treatment to be effective. The specific focus of this book is identifying, categorizing, and analyzing the pervasive foundational causes of ~4000 diseases, allowing these actionable causes to then be eliminated. These foundational causes are based on analysis of hundreds of thousands of biomedical journal articles from the premier medical literature. The foundational causes are categorized and analyzed by discipline, as well as by the underlying main sources of these causes. There is a substantial section outlining the deficiencies and distortions of the premier biomedical literature on which this book is based. These inadequacies lead to 1) concealment of the full extent of the pervasive foundational causes of chronic disease; 2) reduced perceptions of health risk among individuals and policy-makers; 3) inadequate regulation and public health policy at the national and global levels. There is also a lengthy section describing the text mining/ information technology advances that allowed the pervasive foundational causes to be extracted efficiently from the huge volumes of biomedical journal articles retrieved. 5 Pervasive Causes of Disease Copyright © 2015 Ronald N. Kostoff Novelty While the individual direct foundational causes identified in this book are 'known', in the sense that they exist in the published literature, they have not been integrated anywhere near the extent they are integrated in this book. The new 'insights' in this book are: 1) the enormity of potential foundational causes that are possible; 2) the enormity of potential foundational causes that have to be eliminated for any person to prevent or reverse chronic disease (assuming irreversible damage has not been done or overwhelming genetic predisposition is not operable); 3) the enormity of potential combinations of foundational causes that have to be identified and researched (many of whose individual components have not yet been identified); and 4) the depth to which each potential foundational cause must be eliminated for prevention or reversal to occur. Most papers addressing chronic disease take the form: here's a symptom(s); here's what my drug can do to suppress that symptom(s), and here're some of the other symptoms that can arise as a result of my drug. They're using a 22-caliber handgun for a problem that requires a howitzer! Additionally, one chapter (#9) has been devoted to integrating the myriad approaches by which foundational causes have been prevented from appearing in the literature; these causes are therefore not amenable to identification through text mining. The potential enormity of these 'known unknowns' cannot be underestimated! I have not seen any other source that integrates the full spectrum of the types of suppressive approaches identified in Chapter 9. Audience There are three communities to whom this book is targeted. First is the 'disease prevention and reversal' community. This encompasses the public health community, medical practitioners involved clinically with disease prevention and reversal, and individuals interested
Load more

Recommended publications
  • Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism
    International Journal of Molecular Sciences Review Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism Michał Z ˛abczyk 1,2 , Joanna Natorska 1,2 and Anetta Undas 1,2,* 1 John Paul II Hospital, 31-202 Kraków, Poland; [email protected] (M.Z.); [email protected] (J.N.) 2 Institute of Cardiology, Jagiellonian University Medical College, 31-202 Kraków, Poland * Correspondence: [email protected]; Tel.: +48-12-614-30-04; Fax: +48-12-614-21-20 Abstract: Coagulation factor XIII (FXIII) is converted by thrombin into its active form, FXIIIa, which crosslinks fibrin fibers, rendering clots more stable and resistant to degradation. FXIII affects fibrin clot structure and function leading to a more prothrombotic phenotype with denser networks, characterizing patients at risk of venous thromboembolism (VTE). Mechanisms regulating FXIII activation and its impact on fibrin structure in patients with acute VTE encompassing pulmonary embolism (PE) or deep vein thrombosis (DVT) are poorly elucidated. Reduced circulating FXIII levels in acute PE were reported over 20 years ago. Similar observations indicating decreased FXIII plasma activity and antigen levels have been made in acute PE and DVT with their subsequent increase after several weeks since the index event. Plasma fibrin clot proteome analysis confirms that clot-bound FXIII amounts associated with plasma FXIII activity are decreased in acute VTE. Reduced FXIII activity has been associated with impaired clot permeability and hypofibrinolysis in acute PE. The current review presents available studies on the role of FXIII in the modulation of fibrin clot properties during acute PE or DVT and following these events.
    [Show full text]
  • Chloracne: from Clinic to Research
    DERMATOLOGICA SINICA 30 (2012) 2e6 Contents lists available at SciVerse ScienceDirect Dermatologica Sinica journal homepage: http://www.derm-sinica.com REVIEW ARTICLE Chloracne: From clinic to research Qiang Ju 1, Kuochia Yang 2, Christos C. Zouboulis 3, Johannes Ring 4, Wenchieh Chen 4,* 1 Department of Dermatology, Shanghai Skin Disease and STD Hospital, Shanghai, People’s Republic of China 2 Department of Dermatology, Changhua Christian Hospital, Changhua, Taiwan 3 Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Dessau, Germany 4 Department of Dermatology and Allergy, Technische Universität München, Munich, Germany article info abstract Article history: Chloracne is the most sensitive and specific marker for a possible dioxin (2,3,7,8-tetrachlorodibenzo-p- Received: Oct 31, 2011 dioxin) intoxication. It is clinically characterized by multiple acneiform comedone-like cystic eruptions Revised: Nov 9, 2011 mainly involving face in the malar, temporal, mandibular, auricular/retroauricular regions, and the Accepted: Nov 9, 2011 genitalia, often occurring in age groups not typical for acne vulgaris. Histopathology is essential for adefinite diagnosis, which exhibits atrophy or absence of sebaceous glands as well as infundibular Keywords: dilatation or cystic formation of hair follicles, hyperplasia of epidermis, and hyperpigmentation of aryl hydrocarbon receptor stratum corneum. The appearance of chloracne and its clinical severity does not correlate with the blood chloracne “ ” 2,3,7,8-tetrachlorodibenzo-p-dioxin levels of dioxins. Pathogenesis of chloracne remains largely unclear. An aryl hydrocarbon receptor - polyhalogenated aromatic hydrocarbons mediated signaling pathway affecting the multipotent stem cells in the pilosebaceous units is probably sebaceous gland the major molecular mechanism inducing chloracne.
    [Show full text]
  • How Much Do You Know About Fleas, Ticks, Mites and Other Biters? by Vet Glen Cousquer C Norris
    Artful arthropods How much do you know about fleas, ticks, mites and other biters? By vet Glen Cousquer C Norris robably the most historically significant and well known arthropod-borne disease was the “Black Death”. This scourge of the Middle Ages, also known as the Bubonic Plague, killed Pbetween 30 and 60 per cent of Europe’s human population during the 14th Century. This bacterial disease was carried by black rats (Rattus rattus) and transmitted from the rat to humans by the Oriental rat flea (Xenopsylla cheopis). The flea was able to pick up the disease when feeding on rats and then transfer Cheyletiella mites result in the appearance the disease when feeding again on humans. At the time, the of scurf and bald patches in the fur various contributing causes of this devastating disease remained G Cousquer obscure. Our ancestors were largely ignorant of the role played transmit diseases to rabbits. Many of the most important rabbit by the rat, the flea, poor hygiene and inadequate sanitation and diseases are transmitted in this way and we need a detailed this severely hampered their attempts to deal with outbreaks. understanding of the process involved if we are to protect our Today, it is this understanding of how disease can be carried rabbits’ health and welfare. by reservoirs and then transmitted by vectors that allows us to mount more effective responses to such disease threats. So, what are the common arthropod parasites found feeding on rabbits? This feature will look at how certain arthropods play key roles in the transmission of diseases to rabbits.
    [Show full text]
  • Case Report-A 42-Year-Old Lady with Unilateral Leaky Nostril Post Extraction
    Open Access Journal of Dentistry & Oral Disorders Case Report Case Report-A 42-Year-Old Lady with Unilateral Leaky Nostril Post Extraction Tsyeng Ng K*, Ding A, Tay HW and Kovipillai FJ Department of Oral and Maxillofacial Surgery, Taiping Abstract Hospital, Perak, Ministry of Health, Malaysia Background: OroAntral Communication (OAC) is a pathological *Corresponding author: Ng Kar Tsyeng, Department communication between the oral cavity and maxillary sinus that can occur after of Oral and Maxillofacial Surgery, Taiping Hospital, the extraction of maxillary posterior teeth. Left undiagnosed, it will epithelize to Ministry of Health, Malaysia form an Oroantral Fistula (OAF). Received: May 26, 2020; Accepted: June 16, 2020; Case Presentation: This is a case report of a 42-year-old Chinese lady who Published: June 23, 2020 underwent a routine upper posterior tooth extraction and developed oroantral fistula but was misdiagnosed by multiple general practitioners as sinusitis. Conclusion: This report highlights the importance of cross specialty knowledge in the diagnosis of a common but often overlooked condition. Keywords: Oroantral communication; Oroantral fistula; Tooth extraction; Sinusitis; Nasal regurgitation Introduction after the extraction and hence patient did not suspect that it could be due to the extraction as she has had multiple extractions done The maxillary sinuses are bilateral hollow air-filled cavities previously without any complications. In addition, she also noticed rd occupying the upper 2/3 of the maxillary bone. Anatomically, each the occasional salty taste in the mouth. maxillary sinus consists of a roof, lateral walls and floor. It is separated from the oral cavity by the alveolar bone. As a person ages, the sinus We had a high index of suspicion that these symptoms were due will undergo pneumatization, resulting in the roots of the maxillary to the recent history of extraction and hence a diagnostic imaging was teeth projecting into the floor of the maxillary sinus (Figure 1).
    [Show full text]
  • Factor XIII Deficiency
    Factor XIII deficiency Information for families Great Ormond Street Hospital for Children NHS Foundation Trust 2 Factor XIII deficiency is a type of clotting disorder. A specific protein is missing from the blood so that injured blood vessels cannot heal in the usual way. This information sheet from Great Ormond Street Hospital (GOSH) explains the causes, symptoms and treatment of Factor XIII deficiency and where to get help. What is a clotting disorder? A clotting (or coagulation) disorder is a on in order. When all of the factors are turned medical condition where a specific protein on, the blood forms a clot which stops the is missing from the blood. injury site bleeding any further. Blood is made up of different types of There are a number of coagulation factors cells (red blood cells, white blood cells and circulating in the blood, lying in wait to be platelets) all suspended in a straw-coloured turned on when an injury occurs. If any one liquid called plasma. Platelets are the cells of the factors is missing from the body, the responsible for making blood clot. When complicated chemical reaction described a blood vessel is injured, platelets clump above will not happen as it should. This can together to block the injury site. They also lead to blood loss, which can be severe and start off a complicated chemical reaction to life-threatening. Each coagulation factor form a mesh made of a substance called fibrin. is given a number from I to XIII – they are This complicated chemical reaction always always written as Roman numerals – and follows a strict pattern – with each clotting the effects of the missing factor will vary.
    [Show full text]
  • TICKS in RELATION to HUMAN DISEASES CAUSED by <I
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln U.S. Navy Research U.S. Department of Defense 1967 TICKS IN RELATION TO HUMAN DISEASES CAUSED BY RICKETTSIA SPECIES Harry Hoogstraal Follow this and additional works at: https://digitalcommons.unl.edu/usnavyresearch This Article is brought to you for free and open access by the U.S. Department of Defense at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in U.S. Navy Research by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. TICKS IN RELATION TO HUMAN DISEASES CAUSED BY RICKETTSIA SPECIES1,2 By HARRY HOOGSTRAAL Department oj Medical Zoology, United States Naval Medical Research Unit Number Three, Cairo, Egypt, U.A.R. Rickettsiae (185) are obligate intracellular parasites that multiply by binary fission in the cells of both vertebrate and invertebrate hosts. They are pleomorphic coccobacillary bodies with complex cell walls containing muramic acid, and internal structures composed of ribonucleic and deoxyri­ bonucleic acids. Rickettsiae show independent metabolic activity with amino acids and intermediate carbohydrates as substrates, and are very susceptible to tetracyclines as well as to other antibiotics. They may be considered as fastidious bacteria whose major unique character is their obligate intracellu­ lar life, although there is at least one exception to this. In appearance, they range from coccoid forms 0.3 J.I. in diameter to long chains of bacillary forms. They are thus intermediate in size between most bacteria and filterable viruses, and form the family Rickettsiaceae Pinkerton. They stain poorly by Gram's method but well by the procedures of Macchiavello, Gimenez, and Giemsa.
    [Show full text]
  • Journal of Periovision
    CHHATRAPATI SHAHU MAHARAJ SHIKSHAN SANSTHA’S DENTAL COLLEGE & HOSPITAL, KANCHANWADI, PAITHAN ROAD, AURANGABAD OF PERIOVISION JOURNAL OF PERIOVISION OUR INSPIRATION Hon. Shri. Padmakarji Mulay, Hon. Secretary, CSMSS Sanstha MESSAGE FROM THE HON. PRESIDENT Chhatrapati Shahu Maharaj Shikshan Sanstha is one of the leading educational society in the State of Maharashtra. It has been the vanguard of continuous development in professional education since its inception. A thought that has been enduring in mind when it becomes real; is truly an interesting and exciting experience. The 'Periovision' Journal Issue-I will definitely inspire all of us for a new beginning enlightened with hope, confidence and faith in each other o n the road ahead. It will serve to reinforce and allow increased awareness, improved interaction and integration among all of us. I congratulate all the students and faculty members of Dental College & Hospital for taking initiatives and bringing this noble task in reality. Ranjeet P. Mulay Hon. President, CSMSS Sanstha MESSAGE FROM THE HON. TRUSTEE I am delighted that Chhatrapati Shahu Maharaj Shikshan Sanstha’s Dental College & Hospital is bringing out 'Periovision' Journal. It is extremely elite to see that the print edition of 'Periovision' Journal Issue-1 is being published. The journal is now going to be indexed and will be an ideal platform for our researchers to publish their studies especially, Post-Graduate students and faculty of Dental College & Hospital. I wish all success for the Endeavour. Sameer P. Mulay Hon. Trustee, CSMSS Sanstha MESSAGE FROM THE ADMINISTRATIVE OFFICER Chhatrapati Shahu Maharaj Shikshan Sanstha is established in 1986, and the dental college under this sanstha was established in 1991.
    [Show full text]
  • Experiences of Rare Diseases: an Insight from Patients and Families
    Experiences of Rare Diseases: An Insight from Patients and Families Unit 4D, Leroy House 436 Essex Road London N1 3QP tel: 02077043141 fax: 02073591447 [email protected] www.raredisease.org.uk By Lauren Limb, Stephen Nutt and Alev Sen - December 2010 Web and press design www.raredisease.org.uk WordsAndPeople.com About Rare Disease UK Rare Disease UK (RDUK) is the national alliance for people with rare diseases and all who support them. Our membership is open to all and includes patient organisations, clinicians, researchers, academics, industry and individuals with an interest in rare diseases. RDUK was established by Genetic RDUK is campaigning for a Alliance UK, the national charity strategy for integrated service of over 130 patient organisations delivery for rare diseases. This supporting all those affected by would coordinate: genetic conditions, in conjunction with other key stakeholders | Research in November 2008 following the European Commission’s | Prevention and diagnosis Communication on Rare Diseases: | Treatment and care Europe’s Challenges. | Information Subsequently RDUK successfully | Commissioning and planning campaigned for the adoption of the Council of the European into one cohesive strategy for all Union’s Recommendation on patients affected by rare disease in an action in the field of rare the UK. As well as securing better diseases. The Recommendation outcomes for patients, a strategy was adopted unanimously by each would enable the most effective Member State of the EU (including use of NHS resources. the
    [Show full text]
  • WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/05 (2006.01) A61P 31/02 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/CA20 14/000 174 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 4 March 2014 (04.03.2014) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 13/790,91 1 8 March 2013 (08.03.2013) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: LABORATOIRE M2 [CA/CA]; 4005-A, rue kind of regional protection available): ARIPO (BW, GH, de la Garlock, Sherbrooke, Quebec J1L 1W9 (CA). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (72) Inventors: LEMIRE, Gaetan; 6505, rue de la fougere, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Sherbrooke, Quebec JIN 3W3 (CA).
    [Show full text]
  • Compensation for Occupational Skin Diseases
    ORIGINAL ARTICLE http://dx.doi.org/10.3346/jkms.2014.29.S.S52 • J Korean Med Sci 2014; 29: S52-58 Compensation for Occupational Skin Diseases Han-Soo Song1 and Hyun-chul Ryou2 The Korean list of occupational skin diseases was amended in July 2013. The past list was constructed according to the causative agent and the target organ, and the items of that 1 Department of Occupational and Environmental list had not been reviewed for a long period. The revised list was reconstructed to include Medicine, College of Medicine, Chosun University, Gwangju; 2Teo Center of Occupational and diseases classified by the International Classification of Diseases (10th version). Therefore, Environmental Medicine, Changwon, Korea the items of compensable occupational skin diseases in the amended list in Korea comprise contact dermatitis; chemical burns; Stevens-Johnson syndrome; tar-related skin diseases; Received: 19 December 2013 infectious skin diseases; skin injury-induced cellulitis; and skin conditions resulting from Accepted: 2 May 2014 physical factors such as heat, cold, sun exposure, and ionized radiation. This list will be Address for Correspondence: more practical and convenient for physicians and workers because it follows a disease- Han-Soo Song, MD based approach. The revised list is in accordance with the International Labor Organization Department of Occupational and Environmental Medicine, Chosun University Hospital, 365 Pilmun-daero, Dong-gu, list and is refined according to Korean worker’s compensation and the actual occurrence of Gwangju 501-717, Korea occupational skin diseases. However, this revised list does not perfectly reflect the actual Tel: +82.62-220-3689, Fax: +82.62-443-5035 E-mail: [email protected] status of skin diseases because of the few cases of occupational skin diseases, incomplete statistics of skin diseases, and insufficient scientific evidence.
    [Show full text]
  • Dientamoeba Fragilis – the Most Common Intestinal Protozoan in the Helsinki Metropolitan Area, Finland, 2007 to 2017
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Helsingin yliopiston digitaalinen arkisto Research Dientamoeba fragilis – the most common intestinal protozoan in the Helsinki Metropolitan Area, Finland, 2007 to 2017 Jukka-Pekka Pietilä1, Taru Meri2, Heli Siikamäki1, Elisabet Tyyni3, Anne-Marie Kerttula3, Laura Pakarinen1, T Sakari Jokiranta4,5, Anu Kantele1,6 1. Inflammation Center, Infectious Diseases, Helsinki University Hospital and Helsinki University, Helsinki, Finland 2. Molecular and Integrative Biosciences Research Programme, Faculty of Biological and Environmental Sciences, University of Helsinki, Helsinki, Finland 3. Division of Clinical Microbiology, Helsinki University Hospital, HUSLAB, Helsinki, Finland 4. Medicum, University of Helsinki, Finland 5. SYNLAB Finland, Helsinki, Finland 6. Human Microbiome Research Program, Faculty of Medicine, University of Helsinki, Finland Correspondence: Anu Kantele ([email protected]) Citation style for this article: Pietilä Jukka-Pekka, Meri Taru, Siikamäki Heli, Tyyni Elisabet, Kerttula Anne-Marie, Pakarinen Laura, Jokiranta T Sakari, Kantele Anu. Dientamoeba fragilis – the most common intestinal protozoan in the Helsinki Metropolitan Area, Finland, 2007 to 2017. Euro Surveill. 2019;24(29):pii=1800546. https://doi.org/10.2807/1560- 7917.ES.2019.24.29.1800546 Article submitted on 08 Oct 2018 / accepted on 12 Apr 2019 / published on 18 Jul 2019 Background: Despite the global distribution of of Dientamoeba-like structures in formalin-fixed sam- the intestinal protozoan Dientamoeba fragilis, its ples, an approach applicable also in resource-poor clinical picture remains unclear. This results from settings. Symptoms of dientamoebiasis differ slightly underdiagnosis: microscopic screening methods from those of giardiasis; patients with distressing either lack sensitivity (wet preparation) or fail to symptoms require treatment.
    [Show full text]
  • Prevalence and Incidence of Rare Diseases: Bibliographic Data
    Number 1 | January 2019 Prevalence and incidence of rare diseases: Bibliographic data Prevalence, incidence or number of published cases listed by diseases (in alphabetical order) www.orpha.net www.orphadata.org If a range of national data is available, the average is Methodology calculated to estimate the worldwide or European prevalence or incidence. When a range of data sources is available, the most Orphanet carries out a systematic survey of literature in recent data source that meets a certain number of quality order to estimate the prevalence and incidence of rare criteria is favoured (registries, meta-analyses, diseases. This study aims to collect new data regarding population-based studies, large cohorts studies). point prevalence, birth prevalence and incidence, and to update already published data according to new For congenital diseases, the prevalence is estimated, so scientific studies or other available data. that: Prevalence = birth prevalence x (patient life This data is presented in the following reports published expectancy/general population life expectancy). biannually: When only incidence data is documented, the prevalence is estimated when possible, so that : • Prevalence, incidence or number of published cases listed by diseases (in alphabetical order); Prevalence = incidence x disease mean duration. • Diseases listed by decreasing prevalence, incidence When neither prevalence nor incidence data is available, or number of published cases; which is the case for very rare diseases, the number of cases or families documented in the medical literature is Data collection provided. A number of different sources are used : Limitations of the study • Registries (RARECARE, EUROCAT, etc) ; The prevalence and incidence data presented in this report are only estimations and cannot be considered to • National/international health institutes and agencies be absolutely correct.
    [Show full text]